Angiotensin-converting enzyme inhibitors provide a protective effect on hypoxia-induced injury in human coronary artery endothelial cells via Nrf2 signaling and PLVAP
Clinical Hemorheology and Microcirculation · 2024
DOI: 10.3233/ch-232007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Hemorheology and Microcirculation, 2024. Verfasst von Qiubing Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Medical University, Tianjin, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Angiotensin-Converting Enzyme Inhibitors, Signal Transduction, Endothelial Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Angiotensin-converting enzyme inhibitors (ACEIs) were reported to protect from hypoxia-induced oxidative stress in coronary endothelial cells (CECs) after acute myocardial infarction (AMI). Nrf2 shows a protective effect in hypoxia-induced CECs after AMI. Plasmalemma vesicle-associated protein (PLVAP) plays a pivotal role in angiogenesis after AMI. AIM: To explore the protective effect of ACEIs and the involved mechanisms under hypoxia challenge. METHODS: Human coronary endothelial cells (HCAECs) were used to establish hypoxia-induced oxidative stress injury in vitro. Flow cytometry was used to evaluate the protective effect of ACEI on hypoxia conditions.ET-1, NO, ROS, and VEGF were detected by ELISA. HO-1, Nrf2, and Keap-1, the pivotal member in the Nrf2 signaling pathway, eNOS and PLVAP were detected in HEAECs treated with ACEI by immunofluorescence, qPCR, and western blotting. RESULTS: The hypoxia ACEI or Nrf2 agonist groups showed higher cell viability compared with the hypoxia control group at 24 (61.75±1.16 or 61.23±0.59 vs. 44.24±0.58, both P < 0.05) and 48 h (41.85±1.19 or 59.64±1.13 vs. 22.98±0.25, both P < 0.05). ACEI decreased the levels of ET-1 and ROS under hypoxia challenge at 24 and 48 h (all P < 0.05); ACEI increased the VEGF and NO levels (all P < 0.05). ACEI promoted the expression level of eNOS, HO-1, Nrf2 and PLVAP but inhibited Keap-1 expression at the mRNA and protein levels (all P < 0.05). Blockade of the Nrf2 signaling pathway significantly decreased the expression level of PLVAP. CONCLUSION: ACEI protects hypoxia-treated HEAECs by activating the Nrf2 signaling pathway and upregulating the expression of PLVAP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tianjin Medical University, Tianjin, China.
- Department of Cardiology, Guang Yuan Central Hospital, Guang Yuan, China.
- Department of Cardiology, Cangzhou Central Hospital, Tianjin Medical University, Cangzhou, China.
Zitieren
APA
Zhang, Q., Gou, F., Shi, P., Xu, Z., Yan, Z., He, M., Yin, X., He, Y., & Zhang, J. (2024). Angiotensin-converting enzyme inhibitors provide a protective effect on hypoxia-induced injury in human coronary artery endothelial cells via Nrf2 signaling and PLVAP. Clinical Hemorheology and Microcirculation. https://doi.org/10.3233/ch-232007
Vancouver
Zhang Q, Gou F, Shi P, Xu Z, Yan Z, He M, et al. Angiotensin-converting enzyme inhibitors provide a protective effect on hypoxia-induced injury in human coronary artery endothelial cells via Nrf2 signaling and PLVAP. Clinical Hemorheology and Microcirculation. 2024. doi:10.3233/ch-232007
BibTeX
@article{Zhang2024,
author = {Zhang, Qiubing and Gou, Fang and Shi, Ping and Xu, Zhe and Yan, Zhitao and He, Mingfang and Yin, Xiaohong and He, Yuanjun and Zhang, Jun},
title = {Angiotensin-converting enzyme inhibitors provide a protective effect on hypoxia-induced injury in human coronary artery endothelial cells via Nrf2 signaling and PLVAP},
journal = {Clinical Hemorheology and Microcirculation},
year = {2024},
doi = {10.3233/ch-232007}
}
EUVIMED